IP Library Granted Patent US 9,636,171
Granted Patent B2
US 9,636,171 · App. 15/048,005 · Granted May 2, 2017

Methods and systems for endometrial ablation utilizing radio frequency

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,636,171
App. No.
15/048,005
Granted
May 2, 2017
Kind
B2
Abstract

Methods, systems and devices for endometrial ablation. In accordance with a method, a working end of an RF ablation device is positioned in a patient uterus to contact endometrial tissue, the working end comprising a dielectric wall capable of non-expanded and expanded shapes. An indicator mechanism is operatively coupled to the wall and configured to indicate non-expanded and expanded shapes of the wall.

Claims (26)

1. A method for treating uterine tissue, said method comprising:

providing a uterine treatment device having a handle at a proximal end and a thin fluid tight conformable wall at least partially surrounding an interior space at a distal end;

introducing the thin conformable wall into a patient's uterine cavity; and

actuating a first handle component of the handle relative to a second handle component of the handle to expand the thin conformable wall in the uterine cavity;

wherein the actuating step further causes an indicator mechanism on the handle to indicate non-expanded and expanded shapes of the thin conformable wall,

wherein the indicator mechanism comprises first and second indicators disposed adjacent to each other at different positions on the handle and an indicator member, wherein (i) the first and second indicators and are movable relative to the indicator member, and

wherein the non-expanded and expanded shapes of the thin conformable wall are indicated by an axial position of the indicator member relative to the first and second indicators, with the non-expanded shape of the thin conformable wall being indicated by the indicator member being closer to the first indicator than the second indicator and the expanded shape of the thin conformable wall being indicated by the indicator being closer to the second indicator member than the first indicator.

2. The method of claim 1 , wherein the actuating step moves a translatable sleeve coupled to a frame in said interior space which expands the thin conformable wall within the uterine cavity.

3. The method of claim 2 , wherein the actuating step moves the translatable sleeve which includes a proximal end directly coupled to said indicator mechanism.

4. The method of claim 2 , wherein the axial position of the indicator member relative to the first and second indicators further indicates an axial relationship between said translatable sleeve and the second handle component.

5. The method of claim 1 , wherein the thin conformable wall expands to a triangular shape when expanded.

6. The method of claim 1 , wherein the first indicator is configured to provide a first signal when the thin conformable wall is non-expanded and the second indicator is configured to provide a second signal when the thin conformable wall is expanded.

7. The method of claim 1 , wherein the wall is at least partly a dielectric, further comprising delivering ablative energy across the dielectric wall to ablate uterine tissue.

8. The method of claim 7 , wherein RF current is delivered across the dielectric wall.

9. The method of claim 1 , wherein the indicator mechanism is coupled to a controller and enables an RF source to deliver RF current to an electrode arrangement carried at least in part by the conformable wall.

10. The method of claim 9 , wherein the indicator mechanism is coupled to the controller and an absence of threshold expansion of the conformable wall causes the controller to disable the RF source from delivering the RF current to the electrode arrangement.

11. The method of claim 1 , wherein the conformable wall is expanded into a plurality of partially expanded shapes for contacting endometrial tissue in varied shapes of uterine cavities.

12. The method of claim 1 , wherein the conformable wall is expanded into a plurality of partially expanded shapes for contacting endometrial tissue in varied dimension uterine cavities.

13. The method of claim 1 , wherein the indicator mechanism provides at least one of visual, aural or tactile indication.

14. The method of claim 13 , wherein the indicator mechanism provides visual indication of the non-expanded and expanded shapes of the thin conformable wall.

15. The method of claim 14 , wherein the indicator member comprises an indicator arrow pointing toward one or more of the first or second indicators.

16. The method of claim 13 , wherein the first and second indicators have different colors.

17. The method of claim 1 , wherein an energy delivery controller delivers ablative energy through the thin conformable wall to uterine tissue, and wherein the indicator mechanism comprises an electrical sensor operatively coupled to the energy delivery controller such that the controller operates an energy delivery surface of the thin conformable wall responsive to a signal from the indicator mechanism.

18. The method of claim 1 , wherein the first indicator is on the first handle component and the second indicator is also on the first handle component.

19. The method of claim 18 , wherein the indicator member is on the second handle component.

20. The method of claim 1 , wherein the non-expanded shape of the thin conformable wall being indicated by the indicator mechanism also indicates a user to stop proceeding with a procedure in the uterine cavity with the uterine treatment device, and wherein the expanded shape of the thin conformable wall being indicated by the indicator mechanism also indicates the user to go ahead with the procedure.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Feb 5, 2026
From: CANADIAN IMPERIAL BANK OF COMMERCE
To: MINERVA SURGICAL, INC.
Reel/Frame 074721/0585 →
SECURITY INTEREST Recorded Jan 30, 2026
From: AXORA MEDICAL, INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
Reel/Frame 074537/0617 →
RELEASE OF SECURITY INTEREST Recorded Oct 12, 2021
From: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: MINERVA SURGICAL, INC.
Reel/Frame 057770/0451 →
SECURITY INTEREST Recorded Oct 8, 2021
From: MINERVA SURGICAL, INC.
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 057758/0137 →
SECURITY INTEREST Recorded Dec 31, 2019
From: MINERVA SURGICAL, INC.
To: ARES CAPITAL CORPORATION
Reel/Frame 051395/0275 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 5, 2016
From: TOTH, AKOS; HUNDERTMARK, RONALD
To: MINERVA SURGICAL, INC.
Reel/Frame 039074/0051 →